Institut Cochin, Inserm U1016, CNRS UMR-8104, Université Paris Cité, 75014 Paris, France.
CNRS UMR-8601, Université Paris Cité, 75006 Paris, France.
Viruses. 2024 Feb 13;16(2):288. doi: 10.3390/v16020288.
Although cells of the myeloid lineages, including tissue macrophages and conventional dendritic cells, were rapidly recognized, in addition to CD4+ T lymphocytes, as target cells of HIV-1, their specific roles in the pathophysiology of infection were initially largely neglected. However, numerous studies performed over the past decade, both in vitro in cell culture systems and in vivo in monkey and humanized mouse animal models, led to growing evidence that macrophages play important direct and indirect roles as HIV-1 target cells and in pathogenesis. It has been recently proposed that macrophages are likely involved in all stages of HIV-1 pathogenesis, including virus transmission and dissemination, but above all, in viral persistence through the establishment, together with latently infected CD4+ T cells, of virus reservoirs in many host tissues, the major obstacle to virus eradication in people living with HIV. Infected macrophages are indeed found, very often as multinucleated giant cells expressing viral antigens, in almost all lymphoid and non-lymphoid tissues of HIV-1-infected patients, where they can probably persist for long period of time. In addition, macrophages also likely participate, directly as HIV-1 targets or indirectly as key regulators of innate immunity and inflammation, in the chronic inflammation and associated clinical disorders observed in people living with HIV, even in patients receiving effective antiretroviral therapy. The main objective of this review is therefore to summarize the recent findings, and also to revisit older data, regarding the critical functions of tissue macrophages in the pathophysiology of HIV-1 infection, both as major HIV-1-infected target cells likely found in almost all tissues, as well as regulators of innate immunity and inflammation during the different stages of HIV-1 pathogenesis.
尽管髓系细胞,包括组织巨噬细胞和传统树突状细胞,除了 CD4+T 淋巴细胞外,也被迅速识别为 HIV-1 的靶细胞,但它们在感染发病机制中的具体作用最初在很大程度上被忽视了。然而,过去十年中的大量研究,无论是在细胞培养系统中的体外研究,还是在猴子和人源化小鼠动物模型中的体内研究,都提供了越来越多的证据,表明巨噬细胞作为 HIV-1 靶细胞和发病机制中的重要直接和间接作用。最近有人提出,巨噬细胞可能参与 HIV-1 发病机制的所有阶段,包括病毒的传播和扩散,但最重要的是,通过与潜伏感染的 CD4+T 细胞一起,在许多宿主组织中建立病毒储存库,从而在病毒持续性方面发挥作用,这是 HIV 感染者病毒清除的主要障碍。在 HIV-1 感染者的几乎所有淋巴和非淋巴组织中,都可以发现感染的巨噬细胞,它们通常呈多核巨细胞的形式,并表达病毒抗原,在这些组织中,巨噬细胞可能会长时间存在。此外,巨噬细胞还可能直接作为 HIV-1 的靶细胞,或间接作为先天免疫和炎症的关键调节剂,参与 HIV 感染者的慢性炎症和相关临床疾病,即使是在接受有效抗逆转录病毒治疗的患者中也是如此。因此,本综述的主要目的是总结关于组织巨噬细胞在 HIV-1 感染发病机制中的关键作用的最新发现,同时也重新审视旧的数据,这些作用不仅表现在巨噬细胞作为 HIV-1 主要的感染靶细胞,在几乎所有组织中都能被发现,还表现在作为先天免疫和炎症的调节剂,在 HIV-1 发病机制的不同阶段发挥作用。